Compare EIC & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIC | FOCL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.2M | 206.3M |
| IPO Year | 2018 | 1998 |
| Metric | EIC | FOCL |
|---|---|---|
| Price | $8.58 | $3.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $12.63 | $8.80 |
| AVG Volume (30 Days) | ★ 159.4K | 38.0K |
| Earning Date | 05-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 13.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.10 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $8.63 | $3.97 |
| 52 Week High | $12.20 | $6.40 |
| Indicator | EIC | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 31.96 | 37.43 |
| Support Level | N/A | N/A |
| Resistance Level | $10.14 | $4.58 |
| Average True Range (ATR) | 0.24 | 0.29 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 6.54 | 9.59 |
Eagle Point Income Co is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or CLOs, that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.